Status:
COMPLETED
Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level
Lead Sponsor:
Chonbuk National University Hospital
Conditions:
Hyperlipidemias
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
This study was conducted to investigate the effects of daily supplementation of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level.
Detailed Description
This study was a 12-week, randomized, double-blind, placebo-controlled 2x2 cross-over design human trial. 50 subjects which of 25 by group were randomly divided into Red Ginseng Concentrated Powder an...
Eligibility Criteria
Inclusion
- Age 19-70 years with Triglyceride 120-200 mg/dL
Exclusion
- Lipid lowering agent within past 6 months
- Those with clinically significant severe cardiovascular, endocrine, immune, respiratory, liver, biliary, renal and urinary tract, neuropsychiatry, musculoskeletal, inflammatory and hematologic and gastrointestinal disorders
- Persons with significant hypersensitivity reactions to ginseng and red ginseng
- Those with a history of gastrointestinal disorders (ex, Crohn's disease) or gastrointestinal surgery (excluding simple cecal surgery or hernia surgery) that may affect the absorption of a product for clinical trials
- Those who have received antipsychotic medication within 2 months before screening
- Those with a history of alcoholism or substance abuse
- Those who participated in other clinical trials within 2 months before screening
- Laboratory test by show the following results
- Aspartate Transaminase(AST), Alanine Transaminase(ALT) \> Reference range 3 times upper limit
- Serum Creatinine \> 2.0 mg/dL
- Pregnancy or breast feeding
- Those who doesn't accept the implementation of appropriate contraception of a childbearing woman
- Principal Investigator judged inappropriate for participation in study because of Laboratory test result, etc.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 8 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03828188
Start Date
March 1 2018
End Date
May 8 2019
Last Update
May 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center for Functional Foods Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea, 54907